Fecal methylated syndecan-2 (SDC2) testing for early screening of colorectal cancerous and precancerous lesions: A real-world retrospective study in China
Background: Colorectal cancer (CRC) is a major public health concern and the second leading cause of cancer-related deaths worldwide. However, challenges remain in deploying effective screening strategies for early-stage CRC. This study aimed to evaluate the effectiveness of a fecal-based syndecan-2...
Saved in:
Main Authors: | Boyu Qin, Haitao Niu, Lupeng Qiu, Hongfeng Zhou, Peng Lyu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Cancer Pathogenesis and Therapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2949713224000053 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma
by: Doron Yablecovitch, et al.
Published: (2024-09-01) -
Research progress of DNA methylation in the screening of cervical cancer and precancerous lesions
by: Yunge Wang, et al.
Published: (2025-01-01) -
LINE-1 methylation status and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis
by: Akbar Bagheri, et al.
Published: (2025-02-01) -
DNA methylation profiling at base-pair resolution reveals unique epigenetic features of early-onset colorectal cancer in underrepresented populations
by: Jason Sheng Li, et al.
Published: (2025-01-01) -
Spatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneity
by: Binbin Liu, et al.
Published: (2025-01-01)